17/04/2026
April is Testicular Cancer Awareness Month — an important time to highlight not only early detection and treatment, but also the long-term health topics that matter to many patients, including fertility.
Testicular cancer is a highly treatable disease, especially when caught early. However, both the condition itself and its treatments can have an impact on fertility levels and the ability to conceive in the future.
Testicular cancer can affect fertility in several ways:
Some men already experience reduced s***m quality or count at diagnosis, particularly if the cancer affects hormone-producing tissue or disrupts normal testicular function. In other cases, fertility concerns arise mainly from treatment rather than the disease itself.
Common treatments such as surgery, chemotherapy, and radiotherapy can temporarily or permanently reduce s***m production. Chemotherapy and radiation, in particular, may damage the cells responsible for s***m development. The degree of impact depends on the type, dose, and duration of treatment, as well as individual factors like age and baseline fertility.
Despite these risks, many men are still able to father children after treatment. Fertility often recovers over time, especially in cases where only one testicle is affected and the remaining testicle functions normally. For others, assisted reproductive techniques can offer additional options.
Because of this uncertainty, fertility preservation is an important part of care. S***m banking before treatment is a widely recommended and effective option that allows individuals to preserve their chances of biological parenthood in the future.
The key message is that a diagnosis of testicular cancer does not automatically mean infertility. With early planning, modern treatment, and available reproductive technologies, many patients go on to have children after recovery.
Awareness save lives 💜